Clinical Trial Update: Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating peginterferon lambda-1a and ribavirin with telaprevir for hepatitis C; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon lambda-1a (peginterferon lambda-1a)
• Ribavirin (ribavirin)
• Telaprevir (telaprevir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C Virus | Phase 3 | Status: COMPLETED | Results posted: 2019-05-21